We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Zimmer Biomet has secured the US FDA 510(k) clearance for the ROSA Hip System for robotically-assisted direct anterior total hip replacement. ROSA Hip, which is the company’s fourth
The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson,** introduces the INHANCE™ Shoulder System, a first-to-market, fully integrated shoulder arthroplasty
CardioNXT announced today that it received marketing clearance from the U.S. Food and Drug Administration (FDA) for the platform technology comprised of the iMap 3D Navigation & Mapping
Mesago Messe Frankfurt and the Formnext Team is delighted to announce that Formnext will take place as a physical on-site event in Frankfurt from 16 – 19 November
Orthofix Medical has announced the first patient implant in a US Food and Drug Administration (FDA) clinical study of the M6-C artificial cervical disc. The study is being
Lantheus Holdings announced that its subsidiary EXINI Diagnostics has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its digital application aPROMISE. aPROMISE (automated PROstate
Onera Health, a leader in sleep diagnostic and monitoring solutions, closed the Series B funding round today, which brought the total funding raised to date above the €24M
Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health’s Cordis business to H&F. The sale price
French company CARMAT has announced the first implant of its Aeson bioprosthetic artificial heart in a commercial setting in Italy. The implant, which was done at the Azienda
Endologix has secured a Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its Chimney EndoVascular Aneurysm Sealing (ChEVAS) system. The ChEVAS system is is